inocardia limited
inocardia limited Company Information
Company Number
08573417
Next Accounts
Jun 2025
Shareholders
coventry university enterprises limited
helen maddock
View AllGroup Structure
View All
Industry
Research and experimental development on biotechnology
Registered Address
technocentre puma way, coventry, CV1 2TT
Website
www.inocardia.co.ukinocardia limited Estimated Valuation
Pomanda estimates the enterprise value of INOCARDIA LIMITED at £393.1k based on a Turnover of £274.9k and 1.43x industry multiple (adjusted for size and gross margin).
inocardia limited Estimated Valuation
Pomanda estimates the enterprise value of INOCARDIA LIMITED at £0 based on an EBITDA of £-16.9k and a 5.35x industry multiple (adjusted for size and gross margin).
inocardia limited Estimated Valuation
Pomanda estimates the enterprise value of INOCARDIA LIMITED at £908k based on Net Assets of £507k and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Inocardia Limited Overview
Inocardia Limited is a live company located in coventry, CV1 2TT with a Companies House number of 08573417. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in June 2013, it's largest shareholder is coventry university enterprises limited with a 37.9% stake. Inocardia Limited is a established, micro sized company, Pomanda has estimated its turnover at £274.9k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Inocardia Limited Health Check
Pomanda's financial health check has awarded Inocardia Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 7 areas for improvement. Company Health Check FAQs
1 Strong
2 Regular
7 Weak
Size
annual sales of £274.9k, make it smaller than the average company (£3.2m)
- Inocardia Limited
£3.2m - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a slower rate (11.9%)
- Inocardia Limited
11.9% - Industry AVG
Production
with a gross margin of 53.5%, this company has a comparable cost of product (53.5%)
- Inocardia Limited
53.5% - Industry AVG
Profitability
an operating margin of -41.4% make it less profitable than the average company (-1.9%)
- Inocardia Limited
-1.9% - Industry AVG
Employees
with 3 employees, this is below the industry average (44)
3 - Inocardia Limited
44 - Industry AVG
Pay Structure
on an average salary of £75.4k, the company has an equivalent pay structure (£75.4k)
- Inocardia Limited
£75.4k - Industry AVG
Efficiency
resulting in sales per employee of £91.6k, this is less efficient (£127.1k)
- Inocardia Limited
£127.1k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Inocardia Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 54 days, this is quicker than average (62 days)
- Inocardia Limited
62 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Inocardia Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 21 weeks, this is less cash available to meet short term requirements (30 weeks)
21 weeks - Inocardia Limited
30 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 39.2%, this is a lower level of debt than the average (53.5%)
39.2% - Inocardia Limited
53.5% - Industry AVG
INOCARDIA LIMITED financials
Inocardia Limited's latest turnover from September 2023 is estimated at £274.9 thousand and the company has net assets of £507 thousand. According to their latest financial statements, Inocardia Limited has 3 employees and maintains cash reserves of £136 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | ||||||||||
| Other Income Or Grants | ||||||||||
| Cost Of Sales | ||||||||||
| Gross Profit | ||||||||||
| Admin Expenses | ||||||||||
| Operating Profit | ||||||||||
| Interest Payable | ||||||||||
| Interest Receivable | ||||||||||
| Pre-Tax Profit | ||||||||||
| Tax | ||||||||||
| Profit After Tax | ||||||||||
| Dividends Paid | ||||||||||
| Retained Profit | ||||||||||
| Employee Costs | ||||||||||
| Number Of Employees | 3 | 4 | 4 | 3 | 4 | 4 | 5 | 4 | ||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 6,621 | 30,900 | 55,179 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 695,507 | 722,219 | 609,791 | 490,070 | 327,978 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 695,507 | 728,840 | 640,691 | 545,249 | 327,978 | 0 | 0 | 0 | 0 | 0 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 44,613 | 43,409 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 2,276 | 35,667 | 72,592 | 66,175 | 160,877 | 142,350 | 127,629 | 99,878 | 0 | 0 |
| Cash | 136,041 | 43,221 | 189,552 | 213,688 | 40,615 | 122,360 | 90,304 | 139,767 | 104,359 | 114,074 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 138,317 | 78,888 | 262,144 | 279,863 | 201,492 | 264,710 | 217,933 | 239,645 | 148,972 | 157,483 |
| total assets | 833,824 | 807,728 | 902,835 | 825,112 | 529,470 | 264,710 | 217,933 | 239,645 | 148,972 | 157,483 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 18,958 | 8,265 | 6,382 | 2,340 | 5,914 | 37,474 | 61,971 | 44,174 | 29,757 | 55,429 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 307,911 | 183,375 | 78,376 | 191,098 | 129,122 | 126,526 | 66,094 | 14,917 | 0 | 0 |
| total current liabilities | 326,869 | 191,640 | 84,758 | 193,438 | 135,036 | 164,000 | 128,065 | 59,091 | 29,757 | 55,429 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 136,405 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 136,405 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 326,869 | 191,640 | 221,163 | 193,438 | 135,036 | 164,000 | 128,065 | 59,091 | 29,757 | 55,429 |
| net assets | 506,955 | 616,088 | 681,672 | 631,674 | 394,434 | 100,710 | 89,868 | 180,554 | 119,215 | 102,054 |
| total shareholders funds | 506,955 | 616,088 | 681,672 | 631,674 | 394,434 | 100,710 | 89,868 | 180,554 | 119,215 | 102,054 |
| Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 | Sep 2019 | Sep 2018 | Sep 2017 | Sep 2016 | Sep 2015 | Sep 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Operating Profit | ||||||||||
| Depreciation | 6,621 | 24,279 | 24,279 | 18,393 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 90,277 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -33,391 | -36,925 | 6,417 | -94,702 | 18,527 | 14,721 | 27,751 | 55,265 | 1,204 | 43,409 |
| Creditors | 10,693 | 1,883 | 4,042 | -3,574 | -31,560 | -24,497 | 17,797 | 14,417 | -25,672 | 55,429 |
| Accruals and Deferred Income | 124,536 | 104,999 | -112,722 | 61,976 | 2,596 | 60,432 | 51,177 | 14,917 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||||||
| Investing Activities | ||||||||||
| capital expenditure | ||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||||||
| Financing Activities | ||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | -136,405 | 136,405 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||
| interest | ||||||||||
| cash flow from financing | ||||||||||
| cash and cash equivalents | ||||||||||
| cash | 92,820 | -146,331 | -24,136 | 173,073 | -81,745 | 32,056 | -49,463 | 35,408 | -9,715 | 114,074 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 92,820 | -146,331 | -24,136 | 173,073 | -81,745 | 32,056 | -49,463 | 35,408 | -9,715 | 114,074 |
inocardia limited Credit Report and Business Information
Inocardia Limited Competitor Analysis
Perform a competitor analysis for inocardia limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in CV1 area or any other competitors across 12 key performance metrics.
inocardia limited Ownership
INOCARDIA LIMITED group structure
Inocardia Limited has no subsidiary companies.
Ultimate parent company
INOCARDIA LIMITED
08573417
inocardia limited directors
Inocardia Limited currently has 3 directors. The longest serving directors include Dr Helen Maddock (Dec 2013) and Dr Jeremy Billson (Nov 2015).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Dr Helen Maddock | England | 54 years | Dec 2013 | - | Director |
| Dr Jeremy Billson | England | 58 years | Nov 2015 | - | Director |
| Mr Paul Noon | United Kingdom | 56 years | Apr 2017 | - | Director |
P&L
September 2023turnover
274.9k
-23%
operating profit
-113.8k
0%
gross margin
53.6%
+3.46%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
September 2023net assets
507k
-0.18%
total assets
833.8k
+0.03%
cash
136k
+2.15%
net assets
Total assets minus all liabilities
Similar Companies
inocardia limited company details
company number
08573417
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
June 2013
age
12
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
September 2023
previous names
N/A
accountant
-
auditor
-
address
technocentre puma way, coventry, CV1 2TT
Bank
-
Legal Advisor
-
inocardia limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to inocardia limited.
inocardia limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for INOCARDIA LIMITED. This can take several minutes, an email will notify you when this has completed.
inocardia limited Companies House Filings - See Documents
| date | description | view/download |
|---|
